Incyte

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.

CEO

Herve Hoppenot

CEOHerve Hoppenot

Employees

2,617

Employees2,617

Headquarters

Wilmington, Delaware

HeadquartersWilmington, Delaware

Founded

1991

Founded1991

Employees

2,617

Employees2,617

INCY Key Statistics

Market cap

12.67B

Market cap12.67B

Price-Earnings ratio

201.30

Price-Earnings ratio201.30

Dividend yield

—

Dividend yield—

Average volume

1.70M

Average volume1.70M

High today

$65.97

High today$65.97

Low today

$63.93

Low today$63.93

Open price

$64.88

Open price$64.88

Volume

579.38K

Volume579.38K

52 Week high

$83.95

52 Week high$83.95

52 Week low

$53.56

52 Week low$53.56

INCY News

Simply Wall St 3d

Should Weakness in Incyte Corporation's Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Incyte (NASDAQ:INCY) has had a rough three months with its share price down 10%. However, the company's fundamentals look pretty decent, and long-term financial...

Analyst ratings

52%

of 29 ratings

Buy

44.8%

Hold

51.7%

Sell

3.4%

People also own

Based on the portfolios of people who own INCY. This list is generated using Robinhood data, and it’s not a recommendation.